Promising Results in Early-Stage Study of Hodgkin Lymphoma with Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy

Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...

June 16, 2023 | Friday | News
Astellas and Cullgen Forge Strategic Collaboration to Advance Targeted Protein Degraders

Under the terms of the agreement, the two companies aim to develop multiple targeted protein degraders by combining Cullgen's proprietary uSMITE™ tar...

June 15, 2023 | Thursday | News
Future Fields and Jenthera Therapeutics Collaborate on Novel Cancer Biologics Delivery Protein

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protei...

June 14, 2023 | Wednesday | News
Danish National Genome Center Chooses QIAGEN for Oncology Genome Sequencing Variant Interpretation

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its variant interpretation and reporting software, QIAGEN Clinical Insight (QCI) In...

June 14, 2023 | Wednesday | News
Increased Demand for ABA Therapy Requires Precision Treatment Planning to Achieve Timely Access to Care

According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum dis...

June 13, 2023 | Tuesday | News
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced an agreement with The University of Texas MD And...

June 13, 2023 | Tuesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News
Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product bios...

June 12, 2023 | Monday | News
Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility

Ecolab Inc., the world’s water, hygiene and infection prevention company, today announced a further expansion of its Purolite business with the addit...

June 07, 2023 | Wednesday | News
Calder Biosciences announces clinical supply agreement with Biodextris

Calder Biosciences Inc., a molecular engineering and clinical manufacturing-stage biotechnology company pioneering its 3D-Vaxlockä platform techn...

June 07, 2023 | Wednesday | News
WuXi Biologics to Increase Manufacturing Capacity in Germany

-  In response to global clients' increasing demand for contract manufacturing services, WuXi Biologics is expanding its capacity for drug substance a...

June 05, 2023 | Monday | News
Harbour BioMed Initiates Phase I Study of First-in-Class Antibody HBM1020

  HBM1020 is a first-in-class therapeutic monoclonal antibody against B7H7/HHLA2 entering clinical development globally. HBM1020 was generated fro...

June 05, 2023 | Monday | News
Illumina unveils AI software to predict disease-causing genetic mutations in patients

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intellige...

June 02, 2023 | Friday | News
Labcorp Launches Labcorp Plasma Focus™ Liquid Biopsy Test for Precision Oncology

Labcorp (NYSE: LH), a leading global life sciences company, has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection...

June 01, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close